News | 4th July 2024 | 3 mins read
Rapid gassing may not be new, but with several regulators now pushing for it to be adopted in aseptic cleanrooms, deployment is on the rise.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has been advocating for its adoption within the NHS for some time now. Meanwhile, the EU’s introduction of its long-awaited Annex 1 guidelines in August 2023 – for the manufacture of sterile medicinal products – has moved this technology further up the agenda for cleanroom operators.
There’s no doubt rapid gassing will mark a significant step change for operators who are more used to alcohol spray and wipe sterilisation methods – which are currently deployed in most cleanroom environments. Rapid gassing involves the use of vaporised hydrogen peroxide (VHP), which delivers a biological kill to a 6 log reduction.
This technique offers a level of validation and repeatability that is impossible to guarantee with the traditional ‘spray and pray’ approach, which is prone to human error. Accommodating these units in cleanroom environments will require significant investment however and proper preparations will need to be made.
Before this technology is deployed, there are two main areas of forward planning to consider. Firstly, operators will want to guarantee the technology enables optimum production efficiency and secondly they will need to ensure they have the supporting equipment and infrastructure to allow this technology to be implemented.